/PRNewswire/ MedAlliance has announced completion of patient enrolment in the PRISTINE clinical trial with SELUTION SLR™ 018 DEB (drug-eluting balloon) for.
Sirolimus Market Research Report by Application, by Distribution Channel - Global Forecast to 2025 - Cumulative Impact of COVID-19 benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
(MENAFN - Comserve) Shibuya-ku, Tokyo, Japan, Japan, Feb 18, 2021, 09:43 /Comserve / Competitive Analysis: Acotec Scientific, M.A. Med Alliance, ENDOCOR, AR Baltic Medical, iVascular SLU, Concept Medical, Acrostak, Hexacath, Cardionovum, Biosensors International Group
Drug-Coated Balloons Market by Indication (DCB for Peripheral Artery Disease, DCB for Coronary Artery Disease, DCB for Other Indications) Application (Cardiac Catheterization Labs, Hospitals, ASCs) - Global Industry Analysis & Forecast to 2025
Industry Outlook and Trend Analysis
The drug-coated balloons market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Drug-coated balloons (DCBs) are standard (semi-agreeable) angioplasty balloons covered with a cytotoxic chemotherapeutic specialist. Presently, most of commercially accessible drug-coated balloons use paclitaxel. Drug-coated balloons (DCB) are a novel therapeutic procedure for lit